HEALTHTECH SOLUTIONS INC. Inactive Instrument
Healthtech Solutions Inc. Stock Other OTC
Equities
HLTT
US42227P1030
Advanced Medical Equipment & Technology
Financials (USD)
| Sales 2021 | - | Sales 2022 | 1.69 | Capitalization | 20.94M |
|---|---|---|---|---|---|
| Net income 2021 | -9M | Net income 2022 | -3M | EV / Sales 2021 | - |
| Net Debt 2021 | 0.33 | Net Debt 2022 | 3.27 | EV / Sales 2022 | 12,409,039 x |
| P/E ratio 2021 |
-2.1
x | P/E ratio 2022 |
-6.49
x | Employees | - |
| Yield 2021 * |
-
| Yield 2022 |
-
| Free-Float | 64.54% |
More Fundamentals
* Assessed data
More news
More press releases
Healthtech Solutions, Inc. is a life sciences company engaged in building solutions for people and the healthcare system through its subsidiary companies. Its portfolio of subsidiaries includes Healthtech Wound Care, Inc. (HWC), Cellsure, LLC (Cellsure), The Clia Lab, LLC (The Clia Lab), Medi-Scan Inc. (MediScan), and RevHeart Inc. (RevHeart). HWC is focused on identifying and developing a pipeline of human cell and tissue product candidates. Cellsure is engaged in the business of collecting placenta and other birth tissue, then making it available for research and development purposes as well as wound care and surgical treatments. The Clia Lab is a certified diagnostic laboratory, which is dedicated to aiding healthcare providers to screen for and monitor specific diseases. MediScan is a company developing advanced ultrasound imaging and artificial intelligence (AI) based image analysis software. Its portfolio also includes World Reach Holdings, LLC (WR Holdings) and its subsidiaries.
| 1st Jan change | Capi. | |
|---|---|---|
| +4.46% | 32.12B | |
| +13.37% | 7B | |
| +19.61% | 3.64B | |
| -8.78% | 3.4B | |
| -24.45% | 1.29B | |
| -35.53% | 1.12B | |
| +2.79% | 899M | |
| -24.21% | 827M | |
| -39.85% | 808M |
